Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Posts Q2 Revenue Rise, Increased Losses

SAN FRANCISCO, Aug. 6 - Caliper today reported an increase in second quarter revenue and a widened net loss.


For the three months ended June 30, Caliper reported total revenues of $7.2 million compared with $5.3 million for the same period one year ago.


Net loss for the quarter increased to $11.4 million, or $.47 per share, compared to $6.2 million, or $.26 per share, for the year-ago period.


R&D spending rose to approximately $11.5 million from $9.5 million for the second quarter in 2001


The company said it had roughly $137.7 million in cash, cash equivalents, and short term marketable securities as of June 30.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.